This study establishes that targeting tubular senescence is critical for preventing the progression of diabetic kidney disease and identifies inhibition of ASK1 as a novel and clinically applicable strategy to achieve this outcome in patients. The gene discussed is MAP3K5; the disease is diabetic kidney disease.